ProNAi Therapeutics Lands $310,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=597ff1f9-edda-4f5b-80e8-22a113793ba2&Preview=1 -
Date
4/4/2012 -
Company Name
ProNAi Therapeutics -
Mailing Address
2725 South Industrial Hwy Ann Arbor, MI 48104 -
Company Description
ProNAi Therapeutics, Inc. is an emerging biopharmaceutical company that is leveraging its novel and proprietary nucleic acid-based interfering technology, DNAi, to advance a next generation of therapies for patients with cancer and other complex genetic diseases. -
Website
http://www.pronai.com -
Transaction Type
Debt -
Transaction Amount
$310,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
